{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:27:39Z","timestamp":1792301259156,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-024-07069-8","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T08:30:11Z","timestamp":1734769811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Leonardo","family":"Rinaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Crescenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmy","family":"Selman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"key":"7069_CR1","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/oxfordjournals.humrep.a137831","volume":"7","author":"J Smitz","year":"1992","unstructured":"Smitz J, Erard P, Camus M, Devroey P, Tournaye H, Wisanto A, Van Steirteghem AC. Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in desensitization or flare-up protocol. Hum Reprod. 1992;7:1225\u20139.","journal-title":"Hum Reprod"},{"key":"7069_CR2","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/oxfordjournals.humrep.a137976","volume":"8","author":"PF Donderwinkel","year":"1993","unstructured":"Donderwinkel PF, Schoot DC, Pache TD, de Jong FH, Hop WC, Fauser BC. Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with gonadotrophin-releasing hormone agonist. Hum Reprod. 1993;8:2027\u201332.","journal-title":"Hum Reprod"},{"key":"7069_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1530\/jrf.0.0790549","volume":"79","author":"IE Messinis","year":"1987","unstructured":"Messinis IE, Templeton AA. Disparate effects of endogenous and exogenous oestradiol on luteal phase function in women. J Reprod Fertil. 1987;79:549\u201354.","journal-title":"J Reprod Fertil"},{"key":"7069_CR4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/humrep\/16.5.846","volume":"16","author":"FP Hohmann","year":"2001","unstructured":"Hohmann FP, Laven JS, de Jong FH, Eijkemans MJ, Fauser BC. Low-dose exogenous FSH initiated during the early, mid, or late follicular phase can induce multiple dominant follicle development. Hum Reprod. 2001;16:846\u201354.","journal-title":"Hum Reprod"},{"key":"7069_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/oxfordjournals.bmb.a072426","volume":"46","author":"J Smitz","year":"1990","unstructured":"Smitz J, Devroey P, Van Steirteghem AC. Endocrinology in luteal phase and implantation. Br Med Bull. 1990;46:709\u201319.","journal-title":"Br Med Bull"},{"key":"7069_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S1043-2760(03)00075-4","volume":"14","author":"BC Fauser","year":"2003","unstructured":"Fauser BC, Devroey P. Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab. 2003;14:236\u201342.","journal-title":"Trends Endocrinol Metab"},{"key":"7069_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0015-0282(16)45852-8","volume":"36","author":"J Garcia","year":"1981","unstructured":"Garcia J, Jones GS, Acosta AA, Wright GL Jr. Corpus luteum function after follicle aspiration for oocyte retrieval. Fertil Steril. 1981;36:565\u201372.","journal-title":"Fertil Steril"},{"key":"7069_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0015-0282(16)49158-2","volume":"45","author":"J Vargyas","year":"1986","unstructured":"Vargyas J, Kletzky O, Marrs RP. The effect of laparoscopic follicular aspiration on ovarian steroidogenesis during the early preimplantation period. Fertil Steril. 1986;45:221\u20135.","journal-title":"Fertil Steril"},{"key":"7069_CR9","doi-asserted-by":"crossref","unstructured":"Beckers NGM, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K et al. Nonsupplemented luteal phase characteristics after administration of recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in- vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 2003; 88;4186\u20134192.","DOI":"10.1210\/jc.2002-021953"},{"key":"7069_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/GCO.0b013e3281338874","volume":"19","author":"AJ DiLuigi","year":"2007","unstructured":"DiLuigi AJ, Nulsen. JC.Effect of gonadotropin-releasing hormone agonist and antagonist on luteal phase function. Curr Opin Obstet Gynecol. 2007;19:258\u201365.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"7069_CR11","doi-asserted-by":"publisher","first-page":"CD004830","DOI":"10.1002\/14651858","volume":"3","author":"S Daya","year":"2004","unstructured":"Daya S, Gunby JL. Luteal phase support in assisted reproduction cycles. Cochrane Database syst Rev. 2004;3:CD004830. https:\/\/doi.org\/10.1002\/14651858.","journal-title":"Cochrane Database syst Rev"},{"key":"7069_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000084546","volume":"60","author":"S Nosarka","year":"2005","unstructured":"Nosarka S, Kruger T, Siebert I, Grov\u00e9 D. Luteal phase support in in vitro fertilization: meta-analysis of randomized trials. Gynecol Obstet Investig. 2005;60:67\u201374.","journal-title":"Gynecol Obstet Investig"},{"key":"7069_CR13","first-page":"95","volume":"41","author":"J Qiao","year":"2021","unstructured":"Qiao J. Clinical practice guidelines for progesterone in pregnancy maintenance and luteal phase support. Chin J Reprod Contracept. 2021;41:95\u2013105.","journal-title":"Chin J Reprod Contracept"},{"key":"7069_CR14","doi-asserted-by":"publisher","unstructured":"The ESHRE Guideline Group on Ovarian stimulation. and others, ESHRE guideline: ovarian stimulation for IVF\/ICSI. Hum Rerod Open. volume 2020, issue 2, 2020 hoaa009, https:\/\/doi.org\/10.1093\/hropen\/hoaa009","DOI":"10.1093\/hropen\/hoaa009"},{"key":"7069_CR15","doi-asserted-by":"publisher","unstructured":"van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 2015: CD009154. https:\/\/doi.org\/10.1002\/14651858.CD009154.pub3","DOI":"10.1002\/14651858.CD009154.pub3"},{"key":"7069_CR16","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.4103\/0366-6999.235106","volume":"131","author":"HB Chi","year":"2018","unstructured":"Chi HB, Liu NN, Li R, Tao LY, Chen LX, Qiao J. Comparison of vaginal gel and intramuscular progesterone for in vitro fertilization and embryo transfer with gonadotropin-releasing hormone antaganoist protocol. Chin Med J (Engl). 2018;131:1557\u201361.","journal-title":"Chin Med J (Engl)"},{"key":"7069_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejogrb.2019.04.012","volume":"237","author":"H Chi","year":"2019","unstructured":"Chi H, Li R, Qiao J, Chen X, Wang X, Hao G, et al. Vaginal progesterone is non-inferior to intramuscular progesterone in efficacy with acceptable tolerability for luteal phase support; a prospective, randomized, multicenter study in China. Eur J Obstet Gynecol Reprod Biol. 2019;237:100\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"7069_CR18","doi-asserted-by":"publisher","first-page":"e0151388","DOI":"10.1371\/journal.pone.0151388","volume":"11","author":"J Doblinger","year":"2016","unstructured":"Doblinger J, Cometti B, TrevisaniS, Griesinger G. Subcutaneous progesterone is effective and safe for luteal phase support in IVF; an individual patient meta-analysis of the phase III trials. PLoS ONE. 2016;11(3):e0151388. https:\/\/doi.org\/10.1371\/journal.pone.0151388.","journal-title":"PLoS ONE"},{"key":"7069_CR19","first-page":"724","volume":"19","author":"MH Backer Jr","year":"1962","unstructured":"Backer MH Jr. Isopregnenone (Duphaston): a new progestational agent. Obstet Gynecol. 1962;19:724\u20139.","journal-title":"Obstet Gynecol"},{"key":"7069_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.rbmo.2018.11.017","volume":"38","author":"G Griesinger","year":"2019","unstructured":"Griesinger G, Tournaye H, Macklon N, Petraglia F, Arck P, Blockeel C, et al. Dydrogesterone; pharmacological profile and mechanism of action as luteal phase support in assisted reproduction. Reprod Biomed Online. 2019;38:249\u201359.","journal-title":"Reprod Biomed Online"},{"key":"7069_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s43032-023-01302-z","volume":"31","author":"A Patki","year":"2020","unstructured":"Patki A. Role of dydrogesterone for luteal phase support in assisted reproduction. Reprod Sci. 2024;31(1):17\u201329.","journal-title":"Reprod Sci"},{"key":"7069_CR22","first-page":"148","volume":"22","author":"MWP Barbosa","year":"2018","unstructured":"Barbosa MWP, Valadares NPB, Barbosa ACP, Amaral AS, Iglesias JR, Nastri CO, et al. Oral dydrogesterone vs vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis. JBRA Assist Reprod. 2018;22:148\u201356.","journal-title":"JBRA Assist Reprod"},{"key":"7069_CR23","doi-asserted-by":"crossref","unstructured":"Griesinger G, Blockeel C, Kahler E, Pexman-Fieth C, Olofssone JI, Driessen S, et al. Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis. PLoS ONE. 2020. https:\/\/doi.org\/10.371\/journal.pone.0241044.","DOI":"10.1371\/journal.pone.0241044"},{"key":"7069_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12884-023-05570-0","volume":"23","author":"M De","year":"2023","unstructured":"De M, Chen L, Zeng L, Wang Y, Yang R, Li R, et al. Effects of two different types of luteal phase support on pregnancy outcomes following antagonist fresh embryo transfer: a retrospective study. BMC Pregnancy Childbirth. 2023;23:316. https:\/\/doi.org\/10.1186\/s12884-023-05570-0.","journal-title":"BMC Pregnancy Childbirth"},{"key":"7069_CR25","doi-asserted-by":"crossref","unstructured":"Shoham G, Leong M, Weissman A, Barbosa MW, Silva LR, Navarro PA, Ferrani RA, Nastri CO, Martins WP. A 10-year follow-up on the practice of luteal phase support using worldwide web-based surveys. Reprod Biol Endocrinol. Dydrogesterone vs progesterone for luteal phase support: systematic review and meta-analysis of randomized controlled trials. Ultrasound Obstet Gynecol 2016; 48:161\u2013170.","DOI":"10.1002\/uog.15814"},{"key":"7069_CR26","doi-asserted-by":"publisher","unstructured":"Alexander Katalinic, Maria R, Noftz, Juan A, Garcia-Velascoet. No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis. Hum Reprod Open. 2024;1https:\/\/doi.org\/10.1093\/hropen\/hoae004.","DOI":"10.1093\/hropen\/hoae004"},{"key":"7069_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.rbmo.2012.04.005","volume":"25","author":"E Vaisbuch","year":"2012","unstructured":"Vaisbuch E, Leong M, Shoham Z. Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide web-based survey. Reprod Biomed Online. 2012;25:139\u201345.","journal-title":"Reprod Biomed Online"},{"key":"7069_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/09513590701584857","volume":"23","author":"A Patki","year":"2007","unstructured":"Patki A, Pawar VC. Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone. Gynecol Endocrinol. 2007;23:68\u201372.","journal-title":"Gynecol Endocrinol"},{"key":"7069_CR29","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3109\/09513590.2011.569791","volume":"27","author":"V Tomic","year":"2011","unstructured":"Tomic V, Tomic J, Klaic DZ. Oral micronized progesterone combined with vaginal progesterone gel for luteal phase support. Gynecol Endocrinol. 2011;27:1010\u20133.","journal-title":"Gynecol Endocrinol"},{"key":"7069_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.fertnstert.2017.11.004","volume":"109","author":"K Devine","year":"2018","unstructured":"Devine K, Richter KS, Widra EA, McKeeby JL. Vitrified blastocyst transfer cycles with the use of only vaginal progesterone replacement with Endometrin have inferior ongoing pregnancy rates: results from planned interim analysis of a three-arm randomized controlled noninferiority trial. Fertil Steril. 2018;109:266\u201375.","journal-title":"Fertil Steril"},{"key":"7069_CR31","first-page":"101","volume":"55","author":"NS Macklon","year":"2000","unstructured":"Macklon NS, Fauser BC. Impact of ovarian hyperstimulation on the luteal phase. J Reprod Fertil Suppl. 2000;55:101\u20138.","journal-title":"J Reprod Fertil Suppl"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-07069-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-024-07069-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-07069-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T09:03:46Z","timestamp":1734771826000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-024-07069-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["7069"],"URL":"https:\/\/doi.org\/10.1186\/s12884-024-07069-8","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]},"assertion":[{"value":"8 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients were counseled about the nature of the study and gave their written informed consent for their participation in the randomization procedure. All participants were registered in our local ethical committee register (\u201cOne Day Medical Center Ethics Committee\u201d) that approved the study (Protocol \/ Serial number: oneday20161).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All work was carried out in compliance with Ethical Principles for Medical Research Involving Human Subjects outlined in the Helsinki Declaration in 1975 (.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"845"}}